Provider PPI, a U.S. health and wellness organization, has adopted Smith & Nephew’s Episode of Care Assurance Program (eCAP), a solution designed to mitigate risk associated with readmissions in value-based healthcare reimbursement models.
joimax received FDA 510(k) clearance to market Vaporflex® and Legato® electrosurgical probes with radiowave technology for open and endoscopic spine surgery.
Seikagaku entered into an exclusive agreement with Zimmer Biomet for U.S. distribution of VISCO-3â„¢, a 3-injection hyaluronic acid-based viscosupplement for the treatment of knee osteoarthritis pain.
Bone Therapeutics will not pursue U.S. clinical development of PREOB® autologous cell therapy. In the U.S., priority will be given to the development of ALLOB®, with clinical programs to be developed during 2017.
EOS imaging received FDA 510(k) clearance to market kneeEOS, online software that uses weight-bearing 3D images and data to plan Total Knee Arthroplasty.